Top Peptide Therapeutics Companies in Germany

JPT Peptide Technologies is a leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. With over 15 years of experience and ISO 9001:2015 certification, the company offers reliable custom and catalog peptides, peptide microarrays, and libraries, particularly for immunology and proteomics.

The company has developed advanced production technologies and analytical methods for peptide complexes, conducting research on their effectiveness in various applications. Their sophisticated processes and extensive facilities position them as a leader in the peptide market, offering high-tech raw materials for the pharmaceutical, food, and cosmetic industries, including sports nutrition and dietary supplements.

Intavis Peptide Services (IPS) specializes in peptide synthesis and plays a crucial role in vaccine development and personalized cancer therapy. With nearly 30 years of experience, IPS offers comprehensive, customized services that support the entire process from basic research to clinical stages, ensuring innovative peptide solutions for various applications.

PeptaNova has established a well-organized stock of biologically active peptides and related products, thanks to the support of the Peptide Institute. This positions the company as a key supplier of peptide therapeutics in Europe, with exclusive access to additional peptides from Japan.

ABX is a global leader in radiopharmaceuticals, specializing in the development and production of peptides and precursors for radiotracers. They offer custom synthesis and manufacturing of peptide therapeutics in a GMP environment, ensuring high-quality standards and comprehensive documentation.

The company specializes in producing high-quality peptides for various applications, particularly in Immunology, including drug discovery, new therapies, and vaccine development. Their innovative approach and rapid production capabilities position them as a key player in the peptide therapeutics industry.

The company, axxelera, specializes in advanced peptide therapeutics, offering a comprehensive Sars-Cov-2 peptide array that includes the complete spike protein sequence in innovative formats. With over 20 years of experience in high-throughput screening and a fully automated synthesis machine, they provide custom peptide libraries and solutions for proteome-wide studies.

The company specializes in the scalable and cost-efficient production of high-purity peptides and proteins, making them suitable for various mass market applications. They focus on developing innovative peptide and protein-based products, including sustainable alternatives to antibiotics and growth hormones for animal breeding.

Numaferm is a key player in the peptide therapeutics field, boasting over 200 successful peptide projects and specialized services that facilitate the discovery and production of innovative peptides. Their proprietary Numascreen™ phage display libraries and advanced production processes enhance the development of targeted therapies, exemplified by their work on Teriparatide for osteoporosis.

3BP is a leader in peptide therapeutics, specializing in peptide discovery and optimization, with a comprehensive technology platform that supports the entire process from hit identification to early clinical development.